SL Science Holding Limited Ordinary Shares (SLBT)

SL Science Holding Limited Ordinary Shares (SLBT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $869M; returns 1 day -12.2%, 1 week -24.8%.

SL Science Holding Limited is a Taipei-headquartered biomedical firm specializing in next-generation cell and gene therapies, particularly allogeneic 'off-the-shelf' Gamma Delta T (GDT) and Armed-T cell platforms for solid tumors and hematologic malignancies.

Groups SLBT belongs to

• Recent IPOs
• Biotechnology
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Gene Therapy
• Clinical Stage Biotech
• Regenerative Medicine
• Hematologic Malignancies
• Preclinical Development
• Strategic Pivot
• Pancreatic Cancer

SLBT financial model: income statement, cash flow and balance sheet